Free shipping on all orders over $ 500

I-CBP 112

Cat. No. M6808

All AbMole products are for research use only, cannot be used for human consumption.

I-CBP 112 Structure
Size Price Availability Quantity
5mg USD 200  USD200 In stock
10mg USD 350  USD350 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

I-CBP 112 is a cBP/p300 bromodomain inhibitor (IC50 values are 0.142-0.17 and 0.625 μM for CBP and p300 respectively). Selective for CBP and p300 over ATAD2, BAZ2B, BRD2(2), BRD4(1), PB1(5), PCAF, PHIP(2) and TIF1α bromodomains in a BLI assay. Accelerates FRAP recovery in cells at a concentration of 1 μM.

Chemical Information
Molecular Weight 468.59
Formula C27H36N2O5
CAS Number 1640282-31-0
Form Solid
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Boeckler, et al. Proc Natl Acad Sci. Targeted rescue of a destabilized mutant of p53 by an in silico screened drug.

Related Histone Acetyltransferase Products
CBP/p300-IN-5 

P300/CBP-IN-5 is a potent p300/CBP histone acetyltransferase inhibitor, has an IC50 of 18.8 nM.

JG-2016

JG-2016 is a potent inhibitor of histone acetyltransferase 1 (HAT1), with an IC50 of 14.8 μM in the HAT1 acetylation assays.

AU-18069

AU-18069 is a CBP/p300 HAT inhibitor that can be used in studies related to hematological and solid tumors.

KAT modulator-1

KAT modulator-1 is a KAT modulator.

KAT6-IN-1

KAT6-IN-1 is a potent KAT6 inhibitor.

  Catalog
Abmole Inhibitor Catalog




Keywords: I-CBP 112 supplier, Histone Acetyltransferase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.